Elicio Therapeutics Inc. (ELTX) — Cash Flow Quality Index
Elicio Therapeutics Inc. (ELTX) has a Cash Flow Quality Index of -0.96x as of December 2021. Operating cash flow of $-14.36 Million is below net income of $14.89 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Elicio Therapeutics Inc. debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Elicio Therapeutics Inc. Cash Flow Quality Index (2012–2013)
Historical Cash Flow Quality Index for Elicio Therapeutics Inc. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Elicio Therapeutics Inc. (ELTX) cash conversion ratio.
Annual Cash Flow Quality Index for Elicio Therapeutics Inc. (2012–2013)
Year-by-year earnings quality comparison for Elicio Therapeutics Inc..
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2013 | 2.99x | $1.89 Million | $632.24K | ▼ -13.7% |
| 2012 | 3.47x | $1.07 Million | $307.30K | — |